| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$4 |
First Australian Ensight Contract Secured with Lumus Imaging
|
1 Jul 2026 9:10AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
ENL - Price-sensitive ASX Announcement
Full Release
Key Points
- Enlitic Inc. secured its first Australian Ensight contract with Lumus Imaging.
- The agreement is valued at US$248,000 (~A$359,000) over three years.
- Lumus Imaging will deploy the full Ensight platform for hanging protocols, de-identification, and AI validation.
- The contract represents Enlitic's strategic entry into the Australian market.
- This agreement supports Enlitic's transition towards a SaaS revenue model.
- Deployment is facilitated through an existing integration with Intelerad's IntelePACS.
- This move showcases the repeatability of Enlitic's OEM channel deployment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$38 |
EXO-OC algorithm and clinical study update
|
1 Jul 2026 9:10AM |
$0.545 |
$0.270 |
fallen by
50.46%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ's EXO-OC™ test is an exosome-based blood test for early detection of ovarian cancer.
- The EXO-OC™ test uses INOVIQ’s EXO-NET® technology and AI/ML algorithms.
- Initial trials showed 100% sensitivity for stage I/II and 77% sensitivity for all stages at 99.6% specificity.
- Updated algorithm achieved 92.3% sensitivity for stage I/II and 92.5% for all stages at 98% specificity.
- Expanded study faced issues with sample quality, affecting data analysis.
- INOVIQ plans to commercialize EXO-OC™ as a Laboratory Developed Test in the US.
- A provisional patent application for the EXO-OC™ test has been filed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$54 |
Investor webinar invitation
|
1 Jul 2026 9:10AM |
$0.061 |
$0.066 |
risen by
8.20%
|
|
| Centuria Capital Group (CNI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,865 |
Cleansing Notice
|
1 Jul 2026 9:09AM |
$1.930 |
$1.895 |
fallen by
1.81%
|
|
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
Options Lapse and Shortfall Shares Underwritten
|
1 Jul 2026 9:09AM |
$0.088 |
$0.080 |
fallen by
9.09%
|
|
| Black Pearl Group Limited (BPG) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$47 |
Application for quotation of securities - BPG
|
1 Jul 2026 9:07AM |
$0.455 |
$0.480 |
risen by
5.49%
|
|
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$112 |
AUD $3.7M Income Tax Refund Received
|
1 Jul 2026 9:07AM |
$0.405 |
$0.375 |
fallen by
7.41%
|
|
RCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Recce Pharmaceuticals received an AUD $3.7 million income tax refund.
- The refund is for overseas R&D expenditure for FY2025.
- The company plans to raise further capital to support clinical trials.
- Recce is focused on developing synthetic anti-infectives for antibiotic resistance.
- The company expects an additional R&D Tax Incentive rebate in FY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ryder Capital Limited (RYD) ORDINARY FULLY PAID |
Financials |
$142 |
Dividend/Distribution - RYD
|
1 Jul 2026 9:05AM |
$1.730 |
$1.760 |
risen by
1.73%
|
|
RYD - Price-sensitive ASX Announcement
Full Release
Key Points
- Entity name: Ryder Capital Limited
- Security: RYD - Ordinary Fully Paid
- Announcement Type: New announcement
- Distribution Amount: AUD 0.03000000
- Ex Date: 6/7/2026
- Record Date: 7/7/2026
- Payment Date: 21/7/2026
- Currency: AUD - Australian Dollar
- Franked: 100%
- Corporate tax rate for franking credit: 30%
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$102 |
Appendix 3Y Grant of FY27 NED Rights - David Bayes
|
1 Jul 2026 9:05AM |
$0.595 |
$0.605 |
risen by
1.68%
|
|
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$224 |
Update - Notification of buy-back - CDM
|
1 Jul 2026 9:05AM |
$0.750 |
$0.750 |
fallen by
0%
|
|
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$102 |
Appendix 3Y Grant of FY27 NED Rights - Teresa Dyson
|
1 Jul 2026 9:05AM |
$0.595 |
$0.605 |
risen by
1.68%
|
|
| Black Pearl Group Limited (BPG) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$47 |
Capital Change Notice and Warrant Conversion Notice
|
1 Jul 2026 9:05AM |
$0.455 |
$0.480 |
risen by
5.49%
|
|
| International Graphite Limited (IG6) ORDINARY FULLY PAID |
Industrials |
$11 |
Proposed issue of securities - IG6
|
1 Jul 2026 9:04AM |
$0.040 |
$0.041 |
risen by
2.50%
|
|
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$249 |
Trading Halt
|
1 Jul 2026 9:04AM |
$0.540 |
$0.605 |
risen by
12.04%
|
|
IMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by IMB from 1 July 2026.
- Halt is for a significant strategic acquisition announcement.
- Halt will remain until the announcement or 3 July 2026.
- Request made in accordance with ASX Listing Rule 17.1.
- IMB confirms no other reasons to prevent the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$4,488 |
Completion of Peak Hill Gold Project Divestment
|
1 Jul 2026 9:04AM |
$4.700 |
$4.750 |
risen by
1.06%
|
|
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$150 |
WGX: Completion of Peak Hill Gold Project Divestment
|
1 Jul 2026 9:04AM |
$0.075 |
$0.076 |
risen by
1.33%
|
|
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$102 |
Appendix 3Y Grant of FY27 NED Rights - Graham Bradley AO
|
1 Jul 2026 9:04AM |
$0.595 |
$0.605 |
risen by
1.68%
|
|
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$12 |
Second BZDS1901 milestone paid
|
1 Jul 2026 9:03AM |
$0.003 |
$0.004 |
risen by
33.33%
|
|
1AD - Price-sensitive ASX Announcement
Full Release
Key Points
- AdAlta made a US$1 million milestone payment to Shanghai Cell Therapy Group.
- The payment covers five additional mesothelioma patients treated in China.
- New clinical data and manufacturing materials are secured.
- AdAlta completed initial financing obligations for BZDS1901 development.
- Focus shifts to Australian manufacturing and US FDA engagement.
- The strategy aligns with AdAlta's 'East to West' business approach.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$22 |
Investor Presentation - Near Term Work Program
|
1 Jul 2026 9:03AM |
$0.024 |
$0.024 |
fallen by
0%
|
|
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$79 |
Trading Halt
|
1 Jul 2026 9:03AM |
$0.310 |
$0.310 |
fallen by
0%
|
|
AXE - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Archer Materials Limited.
- Pending announcement regarding material capital raising.
- Trading halt to last until 3 July 2026 or until announcement is made.
- No known reasons to deny the trading halt.
- Ensure fair and orderly trading of securities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$24 |
Algorae Awarded NSW Health Public Hospital Supply Contract
|
1 Jul 2026 9:03AM |
$0.010 |
$0.012 |
risen by
20%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Algorae awarded a NSW Health public hospital supply contract.
- Initial contract term of three years, with two optional one-year extensions.
- Contract terms are confidential; revenue recognized within product revenue.
- The award validates Algorae's strategy and commercial capabilities.
- Algorae's dual strategy includes AI-driven drug discovery and commercialization.
- AlgoraeOS platform predicts synergistic drug combinations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beetaloo Energy Australia Limited (BTL) ORDINARY FULLY PAID |
Energy |
$399 |
Beetaloo Operations Update
|
1 Jul 2026 9:02AM |
$0.260 |
$0.265 |
risen by
1.92%
|
|
BTL - Price-sensitive ASX Announcement
Full Release
Key Points
- Carpentaria-5H flow test shows peak gas rate >14 TJ/day and current rate ~6.7 TJ/day.
- The construction of the Carpentaria Gas Plant is on schedule for Q4 2026 gas sales.
- Seismic acquisition for EP167 and EP168 underway, expected to complete by Q3 2026.
- Beetaloo Energy entered agreement with Territory Sands for frac sand supply.
- Initial drawdown on Macquarie Midstream Infrastructure facility completed.
- Company has $63.2 million cash and $42.5 million undrawn facilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$382 |
Update - Notification of buy-back - RG8
|
1 Jul 2026 9:01AM |
$2.740 |
$2.680 |
fallen by
2.19%
|
|
| Macquarie Technology Group Limited (MAQ) ORDINARY FULLY PAID |
Information Technology |
$1,791 |
Change of Director's Interest Notice
|
1 Jul 2026 9:01AM |
$70.120 |
$69.500 |
fallen by
0.88%
|
|
| Australian Oil Company Limited (AOK) ORDINARY FULLY PAID |
Energy |
$5 |
Surat Oil Basin Phase 1 Development Initiatives Commence
|
1 Jul 2026 9:01AM |
$0.002 |
$0.003 |
risen by
25%
|
|
AOK - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1 development initiatives in the Surat Oil Basin have commenced.
- Intervention operations completed on the Emu Apple-1 well, which is now shut in for treatment optimization.
- Riverslea Field development plan is under revision for Riverslea-3 well reinstatement.
- Negotiations are in progress for pumpjack infrastructure deployment to Emu Apple Oil Field.
- Major Gas Field geological mapping is nearing completion.
- Field reinstatements are foundational to the Surat development roadmap.
- Exploration opportunities outside the Surat Basin have been identified and assessed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
